Westwood Holdings Group Inc. Increases Stock Position in The Cooper Companies, Inc. $COO

Westwood Holdings Group Inc. lifted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 23.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 311,745 shares of the medical device company’s stock after purchasing an additional 59,190 shares during the period. Westwood Holdings Group Inc. owned about 0.16% of Cooper Companies worth $22,184,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zions Bancorporation National Association UT acquired a new stake in Cooper Companies during the 1st quarter valued at $33,000. J.Safra Asset Management Corp lifted its position in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after acquiring an additional 340 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies during the first quarter valued at $40,000. Assetmark Inc. increased its position in Cooper Companies by 357.8% during the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after purchasing an additional 483 shares in the last quarter. Finally, Larson Financial Group LLC raised its stake in Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after purchasing an additional 664 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insider Activity at Cooper Companies

In other news, COO Gerard H. Warner III bought 1,450 shares of the firm’s stock in a transaction dated Friday, September 5th. The stock was acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer owned 18,319 shares of the company’s stock, valued at $1,268,224.37. This trade represents a 8.60% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Albert G. White III purchased 10,000 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the acquisition, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at $15,466,466.89. This trade represents a 4.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 17,975 shares of company stock valued at $1,216,346 over the last three months. Insiders own 1.98% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on COO. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. Barclays assumed coverage on shares of Cooper Companies in a research note on Monday, October 13th. They set an “overweight” rating and a $85.00 price objective on the stock. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the stock a “sell” rating in a research note on Wednesday, October 1st. Robert W. Baird cut their price target on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, August 28th. Finally, BNP Paribas raised Cooper Companies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus target price of $84.77.

Cooper Companies Stock Performance

NASDAQ:COO opened at $72.13 on Friday. The company has a market cap of $14.34 billion, a P/E ratio of 35.53, a P/E/G ratio of 1.83 and a beta of 1.02. The firm’s 50 day moving average is $69.70 and its two-hundred day moving average is $72.30. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $106.63. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies announced that its board has initiated a stock repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its shares are undervalued.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.